Just got blasted by the flu for 5 days (nice job with the vaccines this year, Chiron!) but that's over now. Here are the standings as of Friday's close:
By Portfolio Value at 2//18/2005
1 biotek-al $117,128 17.1%
2 Extra Pale $105,254 5.3%
3 fred hayes $103,507 3.5%
4 bio_kruncher $101,373 1.4%
5 former_pgs $100,612 0.6%
6 tom pope $100,484 0.5%
7 Rocky9 $100,394 0.4%
8 BulbaMan $99,361 -0.6%
9 Icebrg $97,178 -2.8%
10 zeta1961 $96,867 -3.1%
11 FiloF $96,374 -3.6%
12 Mike McFarland $96,259 -3.7%
13 Biomaven $93,861 -6.1%
14 Robert C. Jonson $93,530 -6.5%
15 RCMac $93,495 -6.5%
16 mopgcw $92,134 -7.9%
17 georgiabiotech $91,673 -8.3%
18 Richard Harmon $90,596 -9.4%
19 nigel bates $89,750 -10.2%
20 Jorgen Jensen $89,633 -10.4%
21 Biotech Jim $89,392 -10.6%
22 rkrw $89,260 -10.7%
23 WilderElisimo $88,322 -11.7%
24 Bob Cryan $87,542 -12.5%
25 hopper $86,607 -13.4%
26 manny_velasco $86,513 -13.5%
27 quidditch $84,984 -15.0%
28 TexasDude $82,159 -17.8%
29 Miljenko Zuanic $81,464 -18.5%
30 jackelmq $80,800 -19.2%
31 Archimedes $67,844 -32.2%
Aggregate $2,874,348 -7.3%
Biotek-Al's big lead is primarily the result of his 20% in MUCL (basis $.19 now at $.42). (Hope you had lots of it in your personal account, Al.)
A quick look at price action indicates that the penny / lower cost stocks are pretty much the only things that are paying off so far. Returns on the selected stocks will follow... |
